|
ES2527760T3
(es)
|
1998-07-23 |
2015-01-29 |
Yeda Research And Development Co., Ltd. |
Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
|
|
EP1098902A4
(en)
|
1998-07-23 |
2002-07-24 |
Yeda Res & Dev |
TREATMENT OF AUTOIMMUNE DISEASES WITH COPOLYMER 1 AND RELATED COPOLYMERS AND PEPTIDES
|
|
IL140592A0
(en)
*
|
1998-07-23 |
2002-02-10 |
Harvard College |
Synthetic peptides and methods of use for autoimmune disease therapies
|
|
US6800287B2
(en)
|
1998-09-25 |
2004-10-05 |
Yeda Research And Development Co., Ltd. |
Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
|
|
SI1187612T1
(en)
*
|
1999-06-04 |
2005-06-30 |
Vereniging Voor Christelijk Wetenschappelijk Onderwijs |
Use of riluzole for the treatment of multiple sclerosis
|
|
DE60041365D1
(de)
*
|
1999-06-04 |
2009-02-26 |
Vereniging Voor Christelijk Wetenschappelijk Onderwijs |
Verwendung von Riluzol zur Behandlung Multipler Sklerose
|
|
US7022663B2
(en)
|
2000-02-18 |
2006-04-04 |
Yeda Research And Development Co., Ltd. |
Oral, nasal and pulmonary dosage formulations of copolymer 1
|
|
JP2003522799A
(ja)
*
|
2000-02-18 |
2003-07-29 |
イエダ・リサーチ・アンド・ディベロップメント・カンパニー・リミテッド・アット・ザ・ウェイズマン・インスティテュート・オブ・サイエンス |
コポリマー１の経口、経鼻および経肺投与製剤
|
|
IL153236A0
(en)
*
|
2000-06-05 |
2003-07-06 |
Teva Pharma |
The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
|
|
US20020077278A1
(en)
|
2000-06-05 |
2002-06-20 |
Yong V. Wee |
Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
|
|
WO2002076503A1
(en)
|
2000-06-20 |
2002-10-03 |
Mayo Foundation For Medical Education And Research |
Treatment of central nervous system diseases by antibodies against glatiramer acetate
|
|
MXPA04005433A
(es)
|
2001-12-04 |
2004-10-11 |
Teva Pharma |
Proceso para la medicion de la potencia de acetato de glatiramero.
|
|
SI1485127T1
(sl)
|
2002-02-25 |
2011-09-30 |
Elan Pharm Inc |
Dajanje aktivne snovi za zdravljenje vnetja
|
|
AU2004207536B2
(en)
*
|
2003-01-24 |
2010-05-20 |
Elan Pharmaceuticals Inc. |
Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents
|
|
WO2006029411A2
(en)
|
2004-09-09 |
2006-03-16 |
Yeda Research And Development Co. Ltd. |
Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
|
|
SG178495A1
(en)
|
2009-08-20 |
2012-03-29 |
Yeda Res & Dev |
Low frequency glatiramer acetate therapy
|
|
USRE49251E1
(en)
|
2010-01-04 |
2022-10-18 |
Mapi Pharma Ltd. |
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
|
|
US8759302B2
(en)
|
2010-03-16 |
2014-06-24 |
Teva Pharmaceutical Industries, Ltd. |
Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
|
|
US8709433B2
(en)
|
2010-10-11 |
2014-04-29 |
Teva Pharmaceutical Industries Ltd. |
Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
|
|
WO2013055683A1
(en)
|
2011-10-10 |
2013-04-18 |
Teva Pharmaceutical Industries Ltd. |
Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate
|
|
MX2015004563A
(es)
|
2012-10-10 |
2015-07-14 |
Teva Pharma |
Biomarcadores predictivos para respuesta clinica para acetato de glatiramero.
|
|
UY35790A
(es)
|
2013-10-21 |
2015-05-29 |
Teva Pharma |
Marcadores genéticos que predicen la respuesta al acetato de glatiramer
|
|
CN105884866B
(zh)
*
|
2015-01-26 |
2021-04-20 |
漳州未名博欣生物医药有限公司 |
格拉替雷的化学合成方法
|
|
US9155775B1
(en)
|
2015-01-28 |
2015-10-13 |
Teva Pharmaceutical Industries, Ltd. |
Process for manufacturing glatiramer acetate product
|
|
WO2016172855A1
(zh)
*
|
2015-04-28 |
2016-11-03 |
深圳翰宇药业股份有限公司 |
多肽混合物高效液相色谱分析方法
|
|
US12097292B2
(en)
|
2016-08-28 |
2024-09-24 |
Mapi Pharma Ltd. |
Process for preparing microparticles containing glatiramer acetate
|
|
LT3506921T
(lt)
|
2016-08-31 |
2023-08-10 |
Mapi Pharma Ltd |
Ilgesnio atpalaidavimo sistemos, kuriose yra glatiramero acetato
|
|
AU2018242998B2
(en)
|
2017-03-26 |
2023-11-02 |
Mapi Pharma Ltd. |
Glatiramer depot systems for treating progressive forms of multiple sclerosis
|
|
WO2019002228A1
(en)
|
2017-06-26 |
2019-01-03 |
Institut Pasteur |
TREATMENTS TO REMOVE HIV RESERVOIRS AND REDUCE VIRAL LOAD
|